IP Verse

Opiant Pharmaceuticals competitive analysis

Latest PTAB cases involving Opiant Pharmaceuticals

Discover the latest PTAB cases involving Opiant Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 20, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Opiant Pharmaceuticals

IPR2019-00685Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSFinal Written Decision
IPR2019-00686Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00687Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00688Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSFinal Written Decision
IPR2019-00689Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00690Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00691Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00692Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00693Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSInstitution Denied
IPR2019-00694Feb 19, 2019NALOX 1 PHARMACEUTICALSOPIANT PHARMACEUTICALSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Opiant Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 19, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OPIANT PHARMACEUTICALS - - - 15
NALOX 1 PHARMACEUTICALS - - 15 -